Skip to main content Accessibility help
  • Print publication year: 2016
  • Online publication date: April 2016

33 - Radiation Accidents and the Medical Management of Acute Radiation Injury

from Subpart IIIA: - CBRNE and HAZMAT
1. Bennett, B, Repacholi, M, Carr, Z, eds.Health Effects of the Chernobyl Accident and Special Health Care Programmes: Report of the UN Chernobyl Forum Health Expert Group. Geneva, World Health Organization, 2006. (Accessed June 22, 2013).
2. Oliveira, AR, Hunt, JG, Valverde, NJ, Brandao-Mello, CE, Farina, R. Medical and related aspects of the Goiania accident: an overview. Health Physics 1991; 60: 1724.
3. The efforts cited include but are not limited to the establishment of the Domestic Nuclear Detection Office, the development of medical countermeasures against radiation by the National Institute of Allergy and Infectious Diseases and the Biomedical Advanced Research and Development Authority, and the Radiation Event Medical Management website available online at The latter programs are discussed later in this chapter.
4. Tenet, G. At the Center of the Storm: My Years at the CIA. New York, Harper Collins Publishers, 2006; see particularly chapters 14 and 15.
5. Allison, G. Nuclear Terrorism: The Ultimate Preventable Catastrophe. New York, Henry Holt and Company, 2004.
6. Williams, PL. Osama's Revenge: The Next 9/11. Amherst, NY, Prometheus Books, 2004.
7. Ferguson, CD, Potter, WC. The Four Faces of Nuclear Terrorism. Monterey, CA, Monterey Institute for International Studies, 2004.
8. Bailey, MR, Birchall, A, Etherington, G, et al. Individual monitoring conducted by the Health Protection Agency in the London Polonium-210 Incident. HPA-RPD-067. Oxford, Health Protection Agency Centre for Radiation, Chemical and Environmental Hazards Radiation Protection Division, 2010. (Accessed June 22, 2013).
9. McLaughlin, TP, Monahan, SP, Pruvost, NL, Frolov, VV, Ryazanov, BG, Sviridov VI. A Review of Criticality Accidents, 2000 Revision. Los Alamos National Laboratory, Los Alamos, NM, 2000. (Accessed June 22, 2013).
10. Andrews, GA. Criticality accidents in Vinca, Yugoslavia, and Ridge, Oak, Tennessee. Comparison of radiation injuries and results of therapy. JAMA 1962; 179: 191197.
11. Tanaka, SI. Summary of the JCO criticality accident in Tokai-mura and a dose assessment. J Radiat Res (Tokyo) 2001; 42 Suppl: S1S9.
12. Mettler, FA, Voelz, GL, Nenot, J-C, Gusev, IA. Criticality accidents. In: Gusev, IA, Guskova, AK, Mettler, FA, eds., Medical Management of Radiation Accidents. Boca Raton, FL, CRC Press, 2001.
13. Guskova, AK, Gusev, IA. Medical aspects of the accident at Chernobyl. In: Gusev, IA, Guskova, AK, Mettler, FA, eds., Medical Management of Radiation Accidents. Boca Raton, FL, CRC Press, 2001.
14. Cohen, BL. The Nuclear Energy Option: An Alternative for the 90s. New York, Plenum Puiblishing, 1990. (Accessed June 22, 2013).
15. U.S. Nuclear Regulatory Commission. Backgrounder on Chernobyl Nuclear Power Plant Accident. (Accessed June 22, 2013).
16. Crick, MJ, Linsley, GS. An assessment of the radiological impact of the Windscale reactor fire, October 1957. Int J Radiat Biol Rela Stud Phys Chem Med 1984; 46: 479506.
17. U.S. Nuclear Regulatory Commission. Backgrounder on the Three Mile Island Accident. (Accessed June 22, 2013).
18. Tokyo Electric Power Company. Estimation of Radioactive Material Released to the Atmosphere during the Fukushima Daiichi NPS Accident. May 2012. (Accessed June 22, 2013).
19. World Health Organization. Health risk assessment from the nuclear accident after the 2011 Great East Japan Earthquake and Tsunami, based on a preliminary dose estimation. 2013. (Accessed June 22, 2013).
20. United States General Accounting Office. Spent nuclear fuel: options exist to further enhance security. GAO Report No. 03–426. 2003. (Accessed September 5, 2015).
21. Pilkey, OH, Pilkey-Jarvis, L. Useless Arithmetic: Why Environmental Scientists Can't Predict the Future. New York, Columbia University Press, 2007; 20. Langewiesche W. The Atomic Bazaar: The Rise of the Nuclear Poor. New York, Farrar, Straus and Giroux, 2007.
22. Peter, RU, Arsin, H, Cosset, J-M, Clough, K, Gourmelon, P, Nenot, J-C. Accident involving abandoned radioactive sources in Georgia, 1997. In: Gusev, IA, Guskova, AK, Mettler, FA, eds. Medical Management of Radiation Accidents. Boca Raton, FL, CRC Press, 2001.
23. De Oliveira, CN, Melo, DR, Liptzstein, JL. Internal contamination in the Goiânia accident, Brazil, 1987. In: Medical Management of Radiation Accidents.
24. Guskova, AK. Epidemiological evaluation of populations accidentally exposed near the Techa River, Russia. In: Medical Management of Radiation Accidents.
25. Guskova, AK, et al. Acute radiation effects in victims of the Chernobyl accident. UNSCEAR 1988 Report, Appendix to Annex G. (Accessed July 6, 2013).
26. Mettler, FA, Ortiz-Lopez, P. Accidents in radiation therapy. In: Medical Management of Radiation Accidents.
27. Mettler, FA. Accidents at industrial irradiation facilities. In: Medical Management of Radiation Accidents.
28. Zimmerman, PD, Loeb, C. Dirty bombs: the threat revisited. Defense Horizons 2004; 38: 111.
29. Bale, JM. The Chechen resistance and radiological terrorism. Nuclear Threat Initiative Issue Brief. (Accessed September 5, 2015).
30. The Nunn-Lugar Cooperative Threat Reduction (CTR) Program. (Accessed September 5, 2015).
31. Langewiesche, W. The Atomic Bazaar: The Rise of the Nuclear Poor.
32. Bush, Kerry: nukes most serious threat. CNN Newswire. October 9, 2004. (Accessed September 5, 2015).
33. Jackson, D. Obama: nuclear terrorism is ‘the single biggest threat’ to U.S. USA Today. (Accessed June 23, 2013).
34. Glasstone, S, Dolan, P. The Effects of Nuclear Weapons. Department of the Army Pamphlet No. 50–3. Washington, DC, Department of the Army, 1997.
35. HOTSPOT Version 2.06 Nuclear Explosion Program. Lawrence Livermore National Laboratory. (Accessed September 5, 2015). Documentation is within the “Help” function of the computer program.
36. Martin, JE. Physics for Radiation Protection. New York,John Wiley & Sons, 2000.
37. Guskova, AK, et al. Acute radiation effects in victims of the Chernobyl accident. UNSCEAR 1988 Report, Appendix to Annex G. (Accessed September 5, 2015).
38. A notable exception was the accidental exposure of inhabitants of the Marshall Islands to fallout from the detonation of a nuclear device in 1954. Exposures prior to evacuation were estimated to be < 2 Gy in the most severely exposed, with beta burns and mild depression of blood counts being the predominant acute effects. See Cronkite, EP, et al. Medical effects of exposure of human beings to fallout radiation from a thermonuclear explosion. Stem Cells 1995; 13(Suppl. 1): 4957.
39. Hall, EJ. Acute effects of total-body irradiation. In: Hall, EJ, ed. Radiobiology for the Radiologist. Philadelphia, PA, Lippincott Williams & Wilkins, 2000;124135. Of note, however, only one (5%) of the twenty-one Chernobyl emergency workers receiving doses in excess of 650 cGy survived, despite aggressive supportive care (thirteen received allogeneic bone marrow transplants). Fifteen (68%) of the twenty-two emergency responders receiving doses between 420 and 640 cGy survived. See United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation. Annex J: Exposures and effects of the Chernobyl Accident. New York, United Nations, 2000. (Accessed September 5, 2015).
40. Rotblat, J. Acute radiation mortality in a nuclear war. In: Soloman, F, Marston, RQ, eds. The Medical Implications of Nuclear War. Washington, DC, Institute of Medicine, National Academy of Sciences, 1986: 233250. This calculated dose reflected a neutron-dose fraction of < 0.06.
41. Kallman, RF. The effect of dose rate on mode of acute radiation death of C57BL and BALB/c mice. Radiat Res 1962; 16: 796810.
42. Neal, FE. Variation of acute mortality with dose-rate in mice exposed to single large doses of whole-body x-irradiation. Int J Radiat Biol 1960; 2: 295300.
43. Broyles, AA. The effect of dose rate on radiation injury. Health Physics 1989; 56: 933937.
44. MacVittie, TJ, et al. The relative biological effectiveness of mixed fission-neutron-gamma radiation on the hematopoietic syndrome in the canine: effect of therapy on survival. Radiat Res 1991; 128(1 Suppl.): S29S36.
45. Wang, J, et al. The response of dogs to mixed neutron-gamma radiation with different neutron/gamma ratios. Radiat Res 1991; 128(1 Suppl.): S42S46. In this study, the WBC nadir after a 90% neutron exposure of 265 cGy occurred at 5 days while the WBC nadir at the same dose with 15% neutrons occurred at 15–17 days.
46. Cronkite, EP, et al. Medical effects of exposure of human beings to fallout radiation from a thermonuclear explosion. Stem Cells 1995; 13(1 Suppl.): 4957.
47. Kataoka, Y, et al. Antimutagenic effects of radioprotector WR-2721 against fission-spectrum neutrons and 60Co gamma rays in mice. Int J Radiat Biol 1992; 61: 387392.
48. Su, Y, Swift, M. Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann Intern Med 2000; 133: 770778.
49. Carlomagno, F, Chang-Claude, J, Dunning, AM, Ponder, BA. Determination of the frequency of the common 657Del5 Nijmegen breakage syndrome mutation in the German population: no association with risk of breast cancer. Genes Chromosomes Cancer 1999; 25: 393395.
50. Thomson, JF, Tourtellotte, WW, Carttar, MS, Cox, RS, Wilson, JE. Studies on the effects of continuous exposure of animals to gamma radiation from cobalt 60 sources. Am J Roentgenol Radium Ther Nucl Med 1953; 69: 830838.
51. Garner, RJ, et al. Effect of age on the acute lethal response of the beagle to cobalt-60 gamma radiation. Radiat Res 1974; 58: 190195.
52. Casarett, AP. Modification of Radiation Injury. In: Radiation Biology. Englewood Cliffs, NJ, Prentice-Hall, Inc., 1968; 236265.
53. Alexander, GA, Swartz, HM, Amundson, SA, et al. BiodosEPR-2006 Meeting: Acute dosimetry consensus committee recommendations on biodosimetry applications in events involving uses of radiation by terrorists and radiation accidents. Radiat Measurements 2007; 42: 972996.
54. Anno, GH, Young, RW, Bloom, RM, Mercier, JR. Dose response relationships for acute radiation lethality. Health Phys 2003; 84: 565575.
55. Goans, RE. Clinical care of the radiation patient. In: Ricks, RC, Berger, ME, O'Hara, FM, eds. The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims. Nashville, TN, Parthenon Publishing, 2002.
56. Goans, RE, Waselenko, JK. Medical management of radiation casualties. Health Phys 2005; 89: 505512.
57. Coleman, CN, Weinstock, DM, Casagrande, R, et al. Triage and treatment tools for use in a scarce resources-crisis standards of care setting after a nuclear detonation. Disaster Med Public Health Prep March 2011; 5 Suppl. 1): S111S121.
58. Dainiak, N, Gent, RN, Carr, Z, et al. First global consensus for evidence-based management of the hematopoietic syndrome resulting from exposure to ionizing radiation. Disaster Med Public Health Prep October 2011; 5(3): 202212.
59. Sandgren, DJ, Salter, CA, Levine, IH, Ross, JA, Lillis-Hearne, PK, Blakely, WF. Biodosimetry Assessment Tool (BAT) software-dose prediction algorithms. Health Phys 2010; 99(Suppl. 5): S171S183.
60. Blakely, WF, Salter, CA, Prasanna, PG. Early-response biological dosimetry - recommended countermeasure enhancements for mass-casualty radiological accidents and terrorism. Health Phys 2005; 89: 494504.
61. Pantelias, GE, Maillie, HD. The use of peripheral blood mononuclear cell prematurely condensed chromosomes for biological dosimetry. Radiat Res 1984; 99: 140150.
62. Evans, JW, Chang, JA, Giaccia, AJ, Pinkel, D, Brown, JM. The use of fluorescence in situ hybridization combined with premature chromosome condensation for the identification of chromosome damage. Br J Cancer 1991; 63: 517521.
63. Prasanna, PGS, Kolanko, CJ, Gerstenberg, HM, Blakely, WF. Premature condensation assay for biodosimetry: studies with fission neutrons. Health Phys 1997; 72: 594600.
64. Lloyd, DC, Edwards, AA, Moquet, JE, Guerrero-Carbajal, YC. The role of cytogenetics in triage of radiation casualties. Applied Radiation and Isotopes 2000; 52: 11071112.
65. Voisin, P, Benderitter, M, Claraz, M, et al. The cytogenetic dosimetry of recent accidental overexposure. Cell Mol Biol (Noisy-le-grand) 2001; 47: 557564.
66. Blakely, WF, Carr, Z, Chu, MC, et al. WHO 1st consultation on the development of a global biodosimetry laboratories network for radiation emergencies (BioDoseNet). Radiat Res 2009; 171: 127139.
67. Prassanna, PGS, Subramanian, U, Greenhill, RG, Jacocks, JM, Jackson, WE, Blakely, WF. Proceedings of the 36th Health Physics Society Topical Meeting: Radiation Safety Aspects of Homeland Security. San Antonio, TX, 2003; 218222.
68. Maznyk, NA, Wilkins, RC, Carr, Z, Lloyd, DC. The capacity, capabilities and needs of the WHO Biodosenet member laboratories. Radiat Prot Dosimetry 2012; 151: 611620.
69. Kulka, U, Ainsbury, L, Atkinson, M, et al. Realising the European Network of Biodosimetry (RENEB). Radiat Prot Dosimetry 2012; 151: 621625.
70. Prasanna, PGS, Muderhwa, JM, Miller, AC, Grace, MB, Salter, CA, Blakely, WF. Diagnostic biodosimetry for radiation disasters: current research and service activities at AFRRI. In: NATO Medical Surveillance and Response: Research and Technology Opportunities and Options. Neuilly-Sur-Seine, North Atlantic Treaty Organization, 2004.
71. Littlefield, LG, Joiner, EE, Sayer, AM. Cytogenetic analysis of the Juarez radiation accident. In: Mettler, FA, Kelsey, CA, Ricks, RC, eds. Medical Management of Radiation Accidents. Boca Raton, FL, CRC Press, 1989.
72. Sevan' kaev, AV. Results of cytogenetic studies of the consequence of the Chernobyl accident. Radiation Biology Radioecology 2000; 40: 589595.
73. Ramalho, AT, Nascimento, AC. The fate of chromosomal aberrations in 137Cs-exposed individuals in the Goiania radiation accident. Health Phys 1991; 60: 6770.
74. Roy, L, Gregoire, E, Durand, V, et al. 2006. Study of the tools available in biological dosimetry to estimate the dose in cases of accidental complex exposure to ionizing radiation: the Lilo accident. Int J Radiat Biol 2006; 82: 3948.
75. Lindholm, C, Romm, H, Stephan, G, Schmid, E, Moquet, J, Edwards, A. Intercomparison of translocation and dicentric frequencies between laboratories in a follow-up of the radiological accident in Estonia. Int J Radiat Biol 2002; 78: 883890.
76. Koksal, G, Pala, FS, Dalci, DO. In vitro dose response curve for chromosome aberrations induced in human lymphocytes by 60Co irradiation. Mutat Res 1995; 329: 5761.
77. Hayata, I, Kanda, R, Minamihisamatsu, M, Furukawa, M, Sasaki, MS. Cytogenetic dose estimation for 3 severely exposed patients in the JCO criticality accident in Tokai-mura. Journal of Radiation Research 2001; 42: S149S155.
78. Sasaki, MS, Hayata, I, Kamada, N, Kodama, Y, Kodama, S. Chromosome aberration analysis in persons exposed to low-level radiation from the JCO criticality accident in Tokai-mura. Journal of Radiation Research 2001; 42: S107S116.
79. Kanda, R, Minamihisamatsu, M, Hayata, I. Dynamic analysis of chromosome aberrations in three victims of the Tokai-mura criticality accident. Int J Radiat Biol 2002; 78: 857862.
80. El-Naggar, AM, Mohammad, MHM, Gomaa, MA. The radiological accident at Meet Halfa, Qaluobiya, Egypt. In: The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims.
81. Jinaratana, V. The radiological accident in Thailand. In: The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims.
82. Thierens, H, De Ruyck, K, Vral, A, de Gelder, V, Whitehouse, CA, Tawn, EG, Boesman, I. Cytogenetic biodosimetry of an accidental exposure of a radiological worker using multiple assays. Radiat Prot Dosimetry 2005; 113: 408414.
83. Lloyd, DC, Edwards, AA, Moquet, JA, Hone, PA, Szluinska, M. Doses in radiation accidents investigated by chromosome aberration analysis. XXIV. In: Center for Radiation, Chemical and Environmental Hazards, Review of Cases Investigated, 2003–2005. 2006; London, Health Protection Agency, 2006.
84. Voisin, P, Barquinero, R, Blakely, B, et al. Towards a standardization of biological dosimetry by cytogenetics. Cell Mol Biol (Noisy-le-grand) 2002; 48: 501504.
85. Blakely, WF, Brooks, AL, Lofts, RS, van der Schans, GP, Voisin, P. Overview of low-level exposure assessment. Mil Med 2002; 167(2 Suppl.): 2024.
86. Meadows, SK, Dressman, HK, Muramoto, GG, et al. Gene expression signatures of radiation response are specific, durable and accurate in mice and humans. PLoS One April 2, 2008; 3(4): e1912.
87. Tsujii, N, Akashi, M, eds. Proceedings of an International Symposium on the Criticality Accident in Tokai-mura: Medical Aspects of Radiation Emergency. Chiba, National Institute of Radiological Sciences, 2001.
88. Schauer, DA, Coursey, DM, Dick, CE, McLaughlin, WL, Puhl, JM, Desrosiers, MF, Jacobson AD. A radiation accident at an industrial accelerator facility. Health Phys 1993; 65: 131140.
89. Schauer, DA, Desrosiers, MF, Le, FG, Seltzer, FM, Links, JM. EPR dosimetry of cortical bone of tooth enamel irradiated with X and gamma rays: study of energy dependence. Radiat Res 1994; 138: 18.
90. Schauer, DA, Desrosiers, MF, Kuppusamy, P, Zwier, JL. Radiation dosimetry of an accidental overexposure using EPR spectrometry and imaging of human bone. Appl Radiat Isot 1996; 47: 13451350.
91. Romanyukha, AA, Schaur, AA, Thomas, JA, Regulla, DF. Parameters affecting EPR dose reconstruction in teeth. Appl Radiat Isot 2005; 62: 147154.
92. Desrosiers, ME. In vivo assessment of radiation exposure. Health Phys 1991; 61: 859861.
93. Clairand, I, Trompier, F, Bottollier-Depois, JF, Gourmelon, P. Ex vivo ESR measurements associated with Monte Carlo calculations for accident dosimetry: application to the 2001 Georgian accident. Radiat Prot Dosimetry 2006; 119: 500505.
94. Lindholm, C, Salomaa, S, Tekkel, M, Paile, W, Koivistoinen, A, Ilus, T, Veidebaum, T. Biodosimetry after accidental radiation exposure by conventional chromosome analysis and FISH. Int J Radiat Biol 1996; 70: 647656.
95. Hutt, G, Brodski, L, Polyakov, V. Gamma ray assessment after the 1994 radiation accident in Kiisa (Estonia): preliminary results. Applied Radiat Isot 1996; 45: 13291334.
96. Swartz, HM, Iwasaki, A, Tazeusz, W, et al. Measurements of clinically significant doses using non-invasive EPR spectroscopy of teeth in situ. Applied Radiat Isot 2005; 62: 293299.
97. Trompier, F, Tikunov, DD, Ivannikov, A, Clairand, I. ESR investigation of joint use of dentin and tooth enamel to estimate photon and neutron dose components of a mixed field. Radiat Prot Dosimetry 2006; 120: 191196.
98. Kleinerman, RA, Romanyukha, AA, Schauer, DA, Tucker, JD. Retrospective assessment of radiation exposure using biological dosimetry: chromosome painting, electron paramagnetic resonance, and the glycophorin A mutation assay. Radiation Research 2006; 166: 287302.
99. Waselenko, JK, MacVittie, TJ, Blakely, WF, et al. Medical management of the ARS: recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med 2004; 140: 10371051.
100. Goans, RE, Flynn, DF. ARS in Humans. In: Textbook of Military Medicine. Office of the Surgeon General, Department of the Army, Borden Institute, 2012; 1738.
101. Flynn, DF, Goans, RE. Triage and Treatment of Radiation and Combined-injury Casualties. In: Textbook of Military Medicine; 3972.
102. Hogan, DE, Kellison, T. Nuclear terrorism. Am J Med Sci 2002; 323: 341349.
103. Barnett, DJ, Parker, CL, Blodgett, DW, Wierezba, RK, Links, JM. Understanding radiologic and nuclear terrorism as public health threats: preparedness and response perspectives. J Nucl Med 2006; 47: 16531661.
104. U.S. Centers for Disease Control and Prevention. ARS: Fact Sheet for Physicians. (Accessed July 6, 2013).
105. Hall, EJ. Acute effects of total-body irradiation. In: Hall, EJ, ed. Radiobiology for the Radiologist. Philadelphia, PA, Lippincott Williams & Wilkins, 2000.
106. Leikin, JB, McFee, RB, Walter, FG, Edsall, K. A primer for nuclear terrorism. Dis Mon 2003; 49: 485516.
107. Berger, ME, Christensen, DM, Lowry, PC, Jones, OW, Wiley, AL. Medical management of radiation injuries: current approaches. Occup Med (Lond) 2006; 56: 162172.
108. Dainiak, N, Waselenko, JK, Armitage, JO, MacVittie, TJ, Farese, AM. The hematologist and radiation casualties. Hematology Am Soc Hematol Educ Program 2003: 473496.
109. van Bekkum, DW. Radiation sensitivity of the hemopoietic stem cell. Radiat Res 1991; 128(1 Suppl.): S4S8.
110. Koenig, KL, Goans, RE, Hatchett, RJ, Mettler, FA, Schumacher, TA, Noji, EK, Jarrett, DG. Medical treatment of radiological casualties: current concepts. Ann Emerg Med 2005; 45: 643652.
111. Walker, RJ, Willemze, R. Neutrophil kinetics and the regulation of granulopoiesis. Rev Infect Dis 1980; 2: 282292.
112. Chao, NJ. Accidental or intentional exposure to ionizing radiation: biodosimetry and treatment options. Exp Hematol 2007; 35(4 Suppl. 1): 2427.
113. Paris, F, Fuks, Z, Kang, A, et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001; 293: 293297.
114. Maj, JG, Paris, F, Haimovitz-Friedman, A, Venkatraman, E, Kolesnick, R, Fuks, Z. Microvascular function regulates intestinal crypt response to radiation. Cancer Res 2003; 22: 58975906.
115. Schuller, BW, Rogers, AB, Cormier, KS, et al. No significant endothelial apoptosis in the radiation –induced gastrointestinal syndrome. Int J Radiat Oncol Biol Phys 2007; 68: 205210.
116. Seegenschmiedt, H. Management of skin and related reactions to radiotherapy. Front Radiat Ther Oncol 2006; 39: 102119.
117. Hymes, SR, Strom, EA, Fife, C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 2006; 54: 2846.
118. Barabanova, AV. ARS with cutaneous syndrome. In: The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims.
119. Pellmar, TC, Ledney, GD. Combined injury: radiation in combination with trauma, infectious disease, or chemical exposures. Presented at the Human Factors and Medicine Panel Research Task Group 099 (NATO RTG-099 2005), Radiation and Bioeffects and Countermeasures Meeting, Bethesda, Maryland, June 21–23, 2005. Published in Armed Forces Radiobiology Research Institute (AFRRI)-CD-05–2, 2005; 19-1–19-9. Summary at (Accessed July 7, 2013).
120. Pellmar, TC, Ledney, GD. Combined injury: radiation in combination with trauma, infectious disease, or chemical exposures. NATO RTG. 2005;099:19.
121. Brush, J, Lipnick, SL, Phillips, T, Sitko, J, McDonald, JT, McBride, WH. Molecular mechanisms of late normal tissue injury. Semin Radiat Oncol 2007; 17: 121130.
122. Moulder, JE, Cohen, EP. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury. Semin Radiat Oncol 2007; 17: 141148.
123. Robbins, ME, Diz, DI. Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. Int J Radiat Oncol Biol Phys 2006; 64: 612.
124. Richardson, D, Sugiyama, H, Nishi, N, et al. Ionizing radiation and leukemia mortality among Japanese Atomic Bomb Survivors, 1950–2000. Radiat Res 2009; 172: 368382.
125. Preston, DL, Ron, E, Toruoka, S, Funamoto, S, Nishi, N, Soda, M, Mabuchi, K, Kodama, K. Solid cancer incidence in atomic bomb survivors: 1958–1998. Radiat Res 2007; 168: 164.
126. Weisdorf, D, Chao, N, Waselenko, JK, Dainiak, N, Armitage, JO, McNiece, I, Confer, D. Acute radiation injury: contingency planning for triage, supportive care, and transplantation. Biol Blood Marrow Transplant 2006; 12: 672682.
127. Flynn, DF, Goans, RE. Nuclear terrorism: triage and medical management of radiation and combined-injury casualties. Surg Clin North Am 2006; 86: 601636.
128. Casagrande, R, Wills, N, Kramer, E, et al. Using the model of resource and time-based triage (MORTT) to guide scarce resource allocation in the aftermath of a nuclear detonation. Disaster Med Public Health Prep 2011; 5(Suppl. 1): S98S110.
129. Caro, JJ, DeRenzo, EG, Coleman, CN, Weinstock, DM, Knebel, AR. Resource allocation after a nuclear detonation incident: unaltered standards of ethical decision making. Disaster Med Public Health Prep 2011; 5(Suppl. 1): S46S53.
130. DiCarlo, AL, Maher, C, Hick, JL, et al. Radiation injury after a nuclear detonation: medical consequences and the need for scarce resources allocation. Disaster Med Public Health Prep 2011; 5(Suppl. 1): S32S44.
131. Dainiak, N, Gent, RN, Carr, Z, et al. Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems. Disaster Med Public Health Prep October 2011; 5(3): 183201.
133. Barbour, SY, Crawford, J. Hematopoietic growth factors. In: Pazdur, R, Coia, LR, Hoskins, WJ, Wagman, L, eds. Cancer Management: A Multidisciplinary Approach. New York, CMP Healthcare Media, 2006.
134. Bolderston, A, Lloyd, NS, Wong, RK, Holden, L, Robb-Blenderman, L. Supportive Care Guidelines Group of Cancer Care Ontario Program in Evidence-Based Care. The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline. Support Care Cancer 2006; 14: 802817.
135. Farese, AM, Cohen, MV, Katz, BP, Smith, CP, Gibbs, A, Cohen, DM, MacVittie, TJ. Filgrastim improves survival in lethally irradiated nonhuman primates. Radiat Res 2013; 179: 89100.
136. Radiation Injury Treatment Network. ARS Treatment Guidelines. Powerpoint presentation. (Accessed July 7, 2013).
137. Herodin, F, Drouet, M. Cytokine-based treatment of accidentally irradiated victims and new approaches. Exp Hematol 2005; 33: 10711080.
138. Goans, RE. Update on the Treatment of Internal Contamination. In: The Medical Basis for Radiation-Accident Preparedness: The Clinical Care of Victims.
139. Bhattacharyya, MH, Breitenstein, BD, Metivier, H, Muggenburg, BA, Stradling, GN, Volf, V. Guidebook for the Treatment of Accidental Internal Radionuclide Contamination of Workers. eds. Gerber, GB, and Thomas, RG. A Joint Publication for the Commission of the Commission of the European Communities and the US DOE Office of Health and Environmental Research. Radiat Prot Dosim 1992; 41(1): 149.
140. National Council on Radiation Protection & Measurements. Report Number 161. I – Management of Persons Contaminated with Radionuclides: Handbook. 2008.
141. National Council on Radiation Protection & Measurements. Report Number 161. II – Management of Persons Contaminated with Radionuclides: Scientific and Technical Basis. 2008.
142. Mansfield, WG. Nuclear Emergency and Radiological Decision Handbook. Livermore, CA, Lawrence Livermore National Laboratory, 1997.
143. Mettler, F. Personal communication. 2007.
144. Potassium iodide as a thyroiod blocking agent in radiation emergencies. FDA Center for Drug Evaluation and Research Procedural, Rockville, MD, December 2001.…/Guidances/ucm080542.pdf (Accessed July 7, 2013).
145. Norwood, AE, Ursano, RJ, Fullerton, CS. Disaster psychiatry: principles and practice. Psychiatr Q 2000; 71: 207226.
146. Boudreaux, E, Kilpatrick, DG, Resnick, HS, Best, CL, Saunders, BE. Criminal victimization, posttraumatic stress disorder, and comorbid psychopathology among a community sample of women. J Trauma Stress 1998; 11: 665678.
147. Grieger, TA, Waldrep, DA, Lovasz, MM, Ursano, RJ. Follow-up of Pentagon employees two years after the terrorist attack of September 11, 2001. Psychiatr Serv 2005; 56: 13741378.
148. Koenig, KL, Hatchett, R, Crail, S, et al. Report of the Department of Homeland Security Working Group on Radiological Dispersal Device (RDD) Preparedness Medical Preparedness and Response Sub-Group. Washington, DC, Department of Homeland Security, 2003. (Accessed July 7, 2013).
149. International Atomic Energy Agency. The Radiation Accident in Goiania. STI/PUB/815. Vienna, IAEA, 1988.
150. International Atomic Energy Agency. Dosimetric and Medical Aspects of the Radiological Accident in Goiana in 1987. IAEA-TECDOC-1009. Vienna, IAEA, 1998.
151. International Atomic Energy Agency. The Radiation Accident in Tammiku. STI/PUB/1053. Vienna, IAEA, 1998.
152. Goans, RE, Wald, N. Radiation accidents with multi-organ failure in the United States. BJR Suppl 2005; 27: 4146.
153. McLaughlin, TP, Monahas, SP, Pruvost, NL, Frolov, VV, Ryazanov, BG, Sviridov, VI. A Review of Criticality Accidents: 2000 Revision. LA-13638. Los Alamos, NM, Los Alamos National Laboratory, 2000. (Accessed July 7, 2013).
154. Hempelmann, LH, Lisko, L, Hoffman, JG. The ARS: a study of nine cases and a review of the problem. Ann Intern Med 1952; 36: 279510.
155. Shipman, TL, Lushbaugh, LL, Peterson, DF, Langham, WH, Harris, PS, Lawrence, JNP. Acute radiation death resulting from an accidental nuclear critical excursion. J Occup Med Special Supplement 1961: 145192.
156. Karas, JS, Stanbury, JB. Fatal radiation syndrome from an accidental nuclear excursion. N Engl J Med 1965; 272: 755761.
157. Farrell, CL, Bready, JV, Rex, KL, et al. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 1998; 58: 933939.
158. Dörr, W, Noack, R, Spekl, K, Farrell, CL. Modification of oral mucositis by keratinocyte growth factor: single radiation exposure. Int J Radiat Biol 2001; 77: 341347.
159. Hérodin, F, Grenier, N, Drouet, M. Revisiting therapeutic strategies in radiation casualties. Exp Hematol 2007; 35(4 Suppl. 1): 2833.
160. Miller, MC, Nanchahal, J. Advances in the modulation of cutaneous wound healing and scarring. Bio Drugs 2005; 19: 363381.
161. Jurjus, A, Atiyeh, BS, Abdallah, IM, et al. Pharmacological modulation of wound healing in experimental burns. Burns 2007; 33: 892907.
162. Denham, JW, Hauer-Jensen, M. The radiotherapeutic injury – a complex ‘wound.’ Radiother Oncol 2002; 63: 129145.
163. Mustoe, TA, Purdy, J, Gramates, P, Deuel, TF, Thomason, A, Pierce, GF. Reversal of impaired wound healing in irradiated rats by platelet-derived growth factor-BB. Am J Surg 1989; 158: 345350.
164. Amendt, C, Mann, A, Schirmacher, P, Blessing, M. Resistance of keratinocytes to TGFβ-mediated growth restriction and apoptosis induction accelerates re-epithelialization in skin wounds. J Cell Sci 2002; 115: 21892198.
165. Anand, P, Terenghi, G, Warner, G, Kopelman, P, Williams-Chestnut, RE, Sinicropi, DV. The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med 1996; 2: 703707.
166. Kanaan, SA, Saad, eNE,Karam, M, Khansa, H, Jabbur, SJ, Jurjus, AR. Hyperalgesia and upregulation of cytokines and nerve growth factor by cutaneous leishmaniasis in mice. Pain 2000; 85: 477482.
167. Hérodin, F, Roy, L, Grenier, N, et al. Antiapoptotic cytokines in combination with pegfilgrastim soon after irradiation mitigates myelosuppression in nonhuman primates exposed to high irradiation dose. Exp Hematol 2007; 35: 11721181.
168. Candan, F, Alaqözlü, H. Captopril inhibits the pulmonary toxicity of paraquat in rats. Hum Exp Toxicol. 2001;20:637641.
169. He, X, Han, B, Mura, M, et al. Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats. Shock 2007; 28: 106111.
170. Jiang, JS,Wang, LF,Chou, HC, Chen, CM. Angiotensin-converting enzyme inhibitor captopril attenuates ventilator-induced lung injury in rats. J Appl Physiol 2007; 102: 20982103.
171. Moulder, JE, Fish, BL, Cohen, EP. Treatment of radiation nephropathy with ACE inhibitors and AII type-1 and type-2 receptor antagonists. Curr Pharm Des 2007; 13: 13171325.
172. Robbins, ME, Diz, DI. Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects. Int J Radiat Oncol Biol Phys 2006; 64: 612.
173. Dovi, JV, He, LK, DiPietro, LA. Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 2003; 73: 448455.
174. Martin, P, Leibovich, SJ. Inflammatory cells during wound repair: the good, the bad and the ugly. Trends Cell Biol 2005; 15: 599607.
175. Brenner, DJ, Hall, EJ. Computed tomography–an increasing source of radiation exposure. N Engl J Med 2007; 357: 22772284.
176. French Academy of Medicine. Medical Irradiation, Radioactivity Releases, and Disinformation: An Opinion by the Academy of Medicine, December 4, 2001. (Accessed September 5, 2015).
177. International Agency for Research on Cancer. Ionizing Radiation,part I: x- and gamma (γ) radiation and neutrons. IARC Monographs on the evaluation of carcinogenic risks to humans. vol. 75. Lyon, International Agency for Research on Cancer, 2000.
178. National Research Council, Board on Radiation Effects Research. Distribution and Administration of Potassium Iodidein the Event of a Nuclear Accident. Washington, DC, National Academies Press, 2004.
179. Koenig, KL, Bey, T, Bradley, D, Kahn, CA, Schultz, C. The RADPACK: a new concept for stockpiling medical countermeasures for a radiation disaster at the local level. West J Emerg Med 2008; 9(1). (Accessed September 5, 2015).
180. Summary Minutes of the Joint Meeting of the Medical Imaging Drugs Advisory Committee and the Oncologic Drugs Advisory Committee. May 3, 2013. (Accessed July 3, 2014).
181. Castilla, C, Perez-Simon, JA, Sanchez-Guijo, FM, et al. Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD). Biol Blood Marrow Transplant 2006; 12: 936941.
182. Lange, C, Brunswig-Spickenheier, B, Cappallo-Obermann, H, et al. Radiation rescue: mesenchymal stromal cells protect from lethal irradiation. PLoS One 2011; 6(1): e14486.
183. Bey, E, Prat, M, Duhamel, P, et al. Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administration. Wound Repair Regen 2010; 18: 5058.
184. Singh, VK, Christensen, J, Fatanmi, OO, et al. Myeloid progenitors: a radiation countermeasure that is effective when initiated days after irradiation. Radiat Res 2012; 177: 781791.
185. Garg, S, Wang, W, Biju, PG, et al. Bone marrow transplantation helps restore the intestinal mucosal barrier after total body irradiation in mice. Radiat Res 2014; 181: 229239.
186. Goans, RE. Cytogenetic Biodosimetry and Clinical Hematology in the Management of Radiation Injury. Wiley A, Christensen D, eds. Fifth REACTS’ Symposium on the Medical Management of Radiation Injury. Miami, FL, 2011. Oak Ridge Associated Universities. ORAU 12–1771, 2013.
187. Goans, RE, Iddins, CJ, Christensen, DM. Ultrasound & Thermography for Diagnosis of Extent & Magnitude of Acute Local Radiation Injury (LRI). Fifth REACTS’ Symposium on the Medical Management of Radiation Injury. Miami, FL, 2011. Oak Ridge Associated Universities. ORAU 12–1771, 2013.